Estimates of health utility scores in chronic kidney disease

被引:3
|
作者
Sekercioglu, Nigar [1 ]
Curtis, Bryan [1 ,2 ]
Murphy, Sean [1 ,2 ]
Blackhouse, Gord [3 ]
Barrett, Brendan [1 ,2 ]
机构
[1] Mem Univ, Fac Med, Dept Clin Epidemiol, 300 Prince Philip Dr, St John, NF, Canada
[2] Mem Univ, Fac Med, Div Nephrol, 300 Prince Philip Dr, St John, NF, Canada
[3] McMaster Univ, Programs Assessment Technol Hlth, 3 Charlton Ave E,2nd Floor, Hamilton, ON L8N 1Y3, Canada
关键词
Chronic kidney disease; Discrete choice experiment; Parametric inference; Cost-utility analysis; QUALITY-OF-LIFE; PREFERENCE-BASED MEASURE; SF-36; DEPRESSION;
D O I
10.1007/s11255-017-1664-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Coverage decisions in publicly funded healthcare systems require a formal, systematic and transparent assessment process for policies related to distribution of resources. The process is complex and employs multiple types of information, such as clinical effectiveness, costs and health utility scores which are used to produce quality-adjusted life years. The purpose of this study was to create health utility scores for CKD patients within the Canadian population. This is a cross-sectional study of CKD patients. We administered the Short-Form 36 Quality of Life Questions to all participants and employed the Short-Form 6 Dimension index to create health utility scores which were created using a set of parametric preference weights, nonparametric preference weights and ordinal health state valuation techniques obtained from a sample of the general population. Utility values in the dialysis group were lower than in the non-dialysis group. There was a significant relationship between age and health utility scores: As age increases, health utility scores decrease. Diabetes was associated with lower health utility scores in dialysis patients, whereas other covariates did not reach levels of statistical significance in our stepwise regression models. The parametric Bayesian model and standard gamble approach yielded the same results, while the correlation between the nonparametric and parametric methods was above 0.9. Health utility scores were low relative to the general population norm in our study cohort. Longitudinal assessment of CKD patients to capture possible fluctuations in health utility scores may add useful information.
引用
收藏
页码:2043 / 2049
页数:7
相关论文
共 50 条
  • [31] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Benjamin O. Yarnoff
    Thomas J. Hoerger
    Siobhan K. Simpson
    Alyssa Leib
    Nilka R. Burrows
    Sundar S. Shrestha
    Meda E. Pavkov
    BMC Nephrology, 18
  • [32] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Yarnoff, Benjamin O.
    Hoerger, Thomas J.
    Simpson, Siobhan K.
    Leib, Alyssa
    Burrows, Nilka R.
    Shrestha, Sundar S.
    Pavkov, Meda E.
    BMC NEPHROLOGY, 2017, 18
  • [33] CHRONIC KIDNEY DISEASE IN TEXAS: THE UTILITY OF RENAL GENETIC TESTING
    Abdellatif, Abdul
    Beretich, Lauren
    McCormick, Sarah
    Billings, Paul
    Tabriziani, Hossein
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 567 - 567
  • [34] Considering the utility of cognitive remediation therapy in chronic kidney disease
    Tan, Eric J.
    Lee, Stuart J.
    Rossell, Susan L.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (10) : 1259 - 1260
  • [35] Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease
    Cejka, Vladimir
    Stoerk, Stefan
    Nadal, Jennifer
    Schmid, Matthias
    Sommerer, Claudia
    Sitter, Thomas
    Meiselbach, Heike
    Busch, Martin
    Schneider, Markus P.
    Saritas, Turgay
    Schultheiss, Ulla T.
    Kotsis, Fruzsina
    Wanner, Christoph
    Eckardt, Kai-Uwe
    Krane, Vera
    JOURNAL OF RENAL NUTRITION, 2023, 33 (04) : 546 - 554
  • [36] Considering the utility of cognitive remediation therapy in chronic kidney disease
    Eric J. Tan
    Stuart J. Lee
    Susan L. Rossell
    Clinical and Experimental Nephrology, 2019, 23 : 1259 - 1260
  • [37] THE UTILITY OF BIOIMPEDANCE SPECTROSCOPY IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
    Theodoridis, Marios
    Panagoutsos, Stelios
    Roumeliotis, Stefanos
    Bounta, Triantafillia
    Kriki, Pelagia
    Roumeliotis, Athanasios
    Passadakis, Ploumis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 429 - 429
  • [38] Kidney Disease-Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers
    Thaweethamcharoen, Tanita
    Noparatayaporn, Prapaporn
    Sritippayawan, Suchai
    Aiyasanon, Nipa
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 194 - 200
  • [39] HEALTH UTILITY ESTIMATES FOR CONGENITAL CYTOMEGALOVIRUS DISEASE: CONCEPTUAL DESIGN CONSIDERATIONS
    Cawson, M.
    Wolowacz, S.
    Doward, L.
    Sinha, A.
    VALUE IN HEALTH, 2019, 22 : S642 - S642
  • [40] SYSTEMATIC REVIEW OF UTILITY ESTIMATES FOR HEALTH STATES ASSOCIATED WITH CHRONIC MYELOID LEUKEMIA
    Agrawal, R.
    Vieira, J.
    Ryan, J.
    Thakur, D.
    Viana, R.
    VALUE IN HEALTH, 2021, 24 : S31 - S31